Interventional Oncology Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Interventional Oncology Market to 2027 - Global Analysis and Forecasts By Product (Embolization Devices, Ablation Devices, Support Devices); Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization or Selective Internal Radiation Therapy, Transcatheter Arterial Embolization or Bland Embolization); Cancer Type (Liver Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Other Cancers), and Geography

Report Code: TIPRE00005393 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Interventional oncology procedures includes diagnosis and treatment with use of minimally invasive surgery, which are carried under image guidance. Medical devices like X-ray, computed tomography and magnetic resonance imaging is used for the treatment. This technique is generally used for lung cancer, liver cancer and kidney cancer.

MARKET DYNAMICS
The interventional oncology market is to grow exponentially in the forecast period owing to driving factors such as increasing rising preference for minimally invasive surgeries, increase in patient population and increasing public-private funding for interventional oncology. In addition, the emerging economies and growing awareness about interventional oncology is anticipated to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Interventional Oncology Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of interventional oncology market with detailed market segmentation by product, procedure, cancer and geography. The global interventional oncology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading interventional oncology market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global interventional oncology market is segmented on the basis of product, procedure and cancer. Based on product, the market is classified as embolization devices, ablation devices and support devices. On the basis of procedure the market is categorised as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial radioembolization or selective internal radiation and therapy transcatheter arterial embolization or bland embolization. On the basis of cancer type the interventional oncology market is classified as liver cancer, lung cancer, bone cancer, kidney cancer and other cancer.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global interventional oncology market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The interventional oncology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting interventional oncology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the interventional oncology market in these regions.

MARKET PLAYERS
The reports cover key developments in the interventional oncology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from interventional oncology market are anticipated to lucrative growth opportunities in the future with the rising demand for interventional oncology market in the global market. Below mentioned is the list of few companies engaged in the interventional oncology market.

The report also includes the profiles of key interventional oncology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • BTG International Ltd.
  • HealthTronics, Inc.
  • IceCure Medical Ltd
  • IMBIOTECHNOLOGIES LTD.
  • Medtronic
  • MedWaves, Inc.
  • Sanarus
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Interventional Oncology Market - By Product
1.3.2 Interventional Oncology Market - By Procedure
1.3.3 Interventional Oncology Market - By Cancer Type
1.3.4 Interventional Oncology Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTERVENTIONAL ONCOLOGY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTERVENTIONAL ONCOLOGY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTERVENTIONAL ONCOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1. INTERVENTIONAL ONCOLOGY - GLOBAL MARKET OVERVIEW
6.2. INTERVENTIONAL ONCOLOGY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INTERVENTIONAL ONCOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EMBOLIZATION DEVICES
7.3.1. Overview
7.3.2. Embolization Devices Market Forecast and Analysis
7.3.3. Radioembolic Agents Market
7.3.3.1. Overview
7.3.3.2. Radioembolic Agents Market Forecast and Analysis
7.3.4. Non-Radioactive Embolic Agents Market
7.3.4.1. Overview
7.3.4.2. Non-Radioactive Embolic Agents Market Forecast and Analysis
7.4. ABLATION DEVICES
7.4.1. Overview
7.4.2. Ablation Devices Market Forecast and Analysis
7.4.3. Radiofrequency (RF) Ablation Devices Market
7.4.3.1. Overview
7.4.3.2. Radiofrequency (RF) Ablation Devices Market Forecast and Analysis
7.4.4. Microwave Ablation Devices Market
7.4.4.1. Overview
7.4.4.2. Microwave Ablation Devices Market Forecast and Analysis
7.4.5. Cryoablation Devices Market
7.4.5.1. Overview
7.4.5.2. Cryoablation Devices Market Forecast and Analysis
7.4.6. Other Ablation Devices Market
7.4.6.1. Overview
7.4.6.2. Other Ablation Devices Market Forecast and Analysis
7.5. SUPPORT DEVICES
7.5.1. Overview
7.5.2. Support Devices Market Forecast and Analysis
7.5.3. Microcatheters Market
7.5.3.1. Overview
7.5.3.2. Microcatheters Market Forecast and Analysis
7.5.4. Guidewires Market
7.5.4.1. Overview
7.5.4.2. Guidewires Market Forecast and Analysis
8. INTERVENTIONAL ONCOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - PROCEDURE
8.1. OVERVIEW
8.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
8.3. THERMAL TUMOR ABLATION
8.3.1. Overview
8.3.2. Thermal Tumor Ablation Market Forecast and Analysis
8.4. NON-THERMAL TUMOR ABLATION
8.4.1. Overview
8.4.2. Non-Thermal Tumor Ablation Market Forecast and Analysis
8.5. TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
8.5.1. Overview
8.5.2. Transcatheter Arterial Chemoembolization Market Forecast and Analysis
8.6. TRANSCATHETER ARTERIAL RADIOEMBOLIZATION OR SELECTIVE INTERNAL RADIATION THERAPY
8.6.1. Overview
8.6.2. Transcatheter Arterial Radioembolization or Selective Internal Radiation Therapy Market Forecast and Analysis
8.7. TRANSCATHETER ARTERIAL EMBOLIZATION OR BLAND EMBOLIZATION
8.7.1. Overview
8.7.2. Transcatheter Arterial Embolization or Bland Embolization Market Forecast and Analysis
9. INTERVENTIONAL ONCOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - CANCER TYPE
9.1. OVERVIEW
9.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
9.3. LIVER CANCER
9.3.1. Overview
9.3.2. Liver Cancer Market Forecast and Analysis
9.4. LUNG CANCER
9.4.1. Overview
9.4.2. Lung Cancer Market Forecast and Analysis
9.5. BONE CANCER
9.5.1. Overview
9.5.2. Bone Cancer Market Forecast and Analysis
9.6. KIDNEY CANCER
9.6.1. Overview
9.6.2. Kidney Cancer Market Forecast and Analysis
9.7. OTHER CANCERS
9.7.1. Overview
9.7.2. Other Cancers Market Forecast and Analysis
10. INTERVENTIONAL ONCOLOGY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Interventional Oncology Market Overview
10.1.2 North America Interventional Oncology Market Forecasts and Analysis
10.1.3 North America Interventional Oncology Market Forecasts and Analysis - By Product
10.1.4 North America Interventional Oncology Market Forecasts and Analysis - By Procedure
10.1.5 North America Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.1.6 North America Interventional Oncology Market Forecasts and Analysis - By Countries
10.1.6.1 United States Interventional Oncology Market
10.1.6.1.1 United States Interventional Oncology Market by Product
10.1.6.1.2 United States Interventional Oncology Market by Procedure
10.1.6.1.3 United States Interventional Oncology Market by Cancer Type
10.1.6.2 Canada Interventional Oncology Market
10.1.6.2.1 Canada Interventional Oncology Market by Product
10.1.6.2.2 Canada Interventional Oncology Market by Procedure
10.1.6.2.3 Canada Interventional Oncology Market by Cancer Type
10.1.6.3 Mexico Interventional Oncology Market
10.1.6.3.1 Mexico Interventional Oncology Market by Product
10.1.6.3.2 Mexico Interventional Oncology Market by Procedure
10.1.6.3.3 Mexico Interventional Oncology Market by Cancer Type
10.2. EUROPE
10.2.1 Europe Interventional Oncology Market Overview
10.2.2 Europe Interventional Oncology Market Forecasts and Analysis
10.2.3 Europe Interventional Oncology Market Forecasts and Analysis - By Product
10.2.4 Europe Interventional Oncology Market Forecasts and Analysis - By Procedure
10.2.5 Europe Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.2.6 Europe Interventional Oncology Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Interventional Oncology Market
10.2.6.1.1 Germany Interventional Oncology Market by Product
10.2.6.1.2 Germany Interventional Oncology Market by Procedure
10.2.6.1.3 Germany Interventional Oncology Market by Cancer Type
10.2.6.2 France Interventional Oncology Market
10.2.6.2.1 France Interventional Oncology Market by Product
10.2.6.2.2 France Interventional Oncology Market by Procedure
10.2.6.2.3 France Interventional Oncology Market by Cancer Type
10.2.6.3 Italy Interventional Oncology Market
10.2.6.3.1 Italy Interventional Oncology Market by Product
10.2.6.3.2 Italy Interventional Oncology Market by Procedure
10.2.6.3.3 Italy Interventional Oncology Market by Cancer Type
10.2.6.4 Spain Interventional Oncology Market
10.2.6.4.1 Spain Interventional Oncology Market by Product
10.2.6.4.2 Spain Interventional Oncology Market by Procedure
10.2.6.4.3 Spain Interventional Oncology Market by Cancer Type
10.2.6.5 United Kingdom Interventional Oncology Market
10.2.6.5.1 United Kingdom Interventional Oncology Market by Product
10.2.6.5.2 United Kingdom Interventional Oncology Market by Procedure
10.2.6.5.3 United Kingdom Interventional Oncology Market by Cancer Type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Interventional Oncology Market Overview
10.3.2 Asia-Pacific Interventional Oncology Market Forecasts and Analysis
10.3.3 Asia-Pacific Interventional Oncology Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Interventional Oncology Market Forecasts and Analysis - By Procedure
10.3.5 Asia-Pacific Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.3.6 Asia-Pacific Interventional Oncology Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Interventional Oncology Market
10.3.6.1.1 Australia Interventional Oncology Market by Product
10.3.6.1.2 Australia Interventional Oncology Market by Procedure
10.3.6.1.3 Australia Interventional Oncology Market by Cancer Type
10.3.6.2 China Interventional Oncology Market
10.3.6.2.1 China Interventional Oncology Market by Product
10.3.6.2.2 China Interventional Oncology Market by Procedure
10.3.6.2.3 China Interventional Oncology Market by Cancer Type
10.3.6.3 India Interventional Oncology Market
10.3.6.3.1 India Interventional Oncology Market by Product
10.3.6.3.2 India Interventional Oncology Market by Procedure
10.3.6.3.3 India Interventional Oncology Market by Cancer Type
10.3.6.4 Japan Interventional Oncology Market
10.3.6.4.1 Japan Interventional Oncology Market by Product
10.3.6.4.2 Japan Interventional Oncology Market by Procedure
10.3.6.4.3 Japan Interventional Oncology Market by Cancer Type
10.3.6.5 South Korea Interventional Oncology Market
10.3.6.5.1 South Korea Interventional Oncology Market by Product
10.3.6.5.2 South Korea Interventional Oncology Market by Procedure
10.3.6.5.3 South Korea Interventional Oncology Market by Cancer Type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Interventional Oncology Market Overview
10.4.2 Middle East and Africa Interventional Oncology Market Forecasts and Analysis
10.4.3 Middle East and Africa Interventional Oncology Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Interventional Oncology Market Forecasts and Analysis - By Procedure
10.4.5 Middle East and Africa Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.4.6 Middle East and Africa Interventional Oncology Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Interventional Oncology Market
10.4.6.1.1 South Africa Interventional Oncology Market by Product
10.4.6.1.2 South Africa Interventional Oncology Market by Procedure
10.4.6.1.3 South Africa Interventional Oncology Market by Cancer Type
10.4.6.2 Saudi Arabia Interventional Oncology Market
10.4.6.2.1 Saudi Arabia Interventional Oncology Market by Product
10.4.6.2.2 Saudi Arabia Interventional Oncology Market by Procedure
10.4.6.2.3 Saudi Arabia Interventional Oncology Market by Cancer Type
10.4.6.3 U.A.E Interventional Oncology Market
10.4.6.3.1 U.A.E Interventional Oncology Market by Product
10.4.6.3.2 U.A.E Interventional Oncology Market by Procedure
10.4.6.3.3 U.A.E Interventional Oncology Market by Cancer Type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Interventional Oncology Market Overview
10.5.2 South and Central America Interventional Oncology Market Forecasts and Analysis
10.5.3 South and Central America Interventional Oncology Market Forecasts and Analysis - By Product
10.5.4 South and Central America Interventional Oncology Market Forecasts and Analysis - By Procedure
10.5.5 South and Central America Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.5.6 South and Central America Interventional Oncology Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Interventional Oncology Market
10.5.6.1.1 Brazil Interventional Oncology Market by Product
10.5.6.1.2 Brazil Interventional Oncology Market by Procedure
10.5.6.1.3 Brazil Interventional Oncology Market by Cancer Type
10.5.6.2 Argentina Interventional Oncology Market
10.5.6.2.1 Argentina Interventional Oncology Market by Product
10.5.6.2.2 Argentina Interventional Oncology Market by Procedure
10.5.6.2.3 Argentina Interventional Oncology Market by Cancer Type
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INTERVENTIONAL ONCOLOGY MARKET, KEY COMPANY PROFILES
12.1. BTG INTERNATIONAL LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. HEALTHTRONICS, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ICECURE MEDICAL LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. IMBIOTECHNOLOGIES LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MEDTRONIC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MEDWAVES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANARUS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TELEFLEX INCORPORATED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TERUMO CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TROD MEDICAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. BTG International Ltd.
2. HealthTronics, Inc.
3. IceCure Medical Ltd
4. IMBIOTECHNOLOGIES LTD.
5. Medtronic
6. MedWaves, Inc.
7. Sanarus
8. Teleflex Incorporated
9. Terumo Corporation
10. Trod Medical
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book